differ cystic fibrosi normal saliva alphaamylas function age sex alphaamylas activ protein concentr cystic fibrosi cf oblig heterozygot h normal n saliva evalu respect genotyp age sex clinic statu factor present cf saliva detect effect salivari amylas activ reaction condit optim competit noncompetit inhibit tri trishydoxymethylaminomethan inhibit amylas activ ki 59 plu minu 10 mm cf factor detect effect either substrat tri bind alphaamylas alphaamylas concentrationand protein content cf saliva bimod distribut thirtysix percent cf patient found amylas hypersecretor amylas concentr 3 sd n mean amylas hypersecret margin correl genet factor parent valu p 0075 clinic statu scwachman score p 0068 hypersecretor 1424 year age group amylas concentr age signific higher cf sampl mean plu minu sd 82 plu minu 37 starch unitsml n 12 n sampl 33 plu minu 17 starch unitesml n 13 measur student ttest p 0001 salivari protein content 14 24yearold cf male elev compar group 157 plu minu 076 n 5 vs 063 plu minu 047 n 20 student ttest p 0005 mean specif activ male saliva drop sharpli age increas 1015 year 200 less 75 starch unitsmg protein mean normal femal specif activ valu essenti constant 97 plu minu 50 n 18 starch unitsmg protein 530 year age cf male specif activ valu decreas similarli n male valu preadolesc adolesc mean cf femal valu peak later 17 year maximum 171 plu minu 58 n 4 significantli higher group 16 20year age rang 63 plu minu 30 n 9 p 0005 data emphas need age sexmatch control studi salivari composit unabl detect effect salivari cf factor enzymat activ alphaamylas hypersecret salivari alphaamylas observ 36 cf patient may reflect alter secretori function basic cf secondari diseas process result decreas secret mucou salivari gland deterior pancreat function